Published on
March 14, 2019
- 05:38 GMT
EOFlow Receives FDA Breakthrough Device Designation on its Integrated Wearable Automated Insulin Delivery System
SAN JOSE, CA, USA, March 14, 2019 /EINPresswire.com/ -- EOFLOW CO., Ltd., an emerging medical device manufacturer with offices in Seoul, South Korea and San Jose, California, announced today that its closed loop Automated Insulin Delivery /Artificial …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...